NICORISCOVID - Measurement of the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2

Head :
KARMOCHKINE Marina, no

Last update : 05/05/2021 | Version : 1 | ID : 73679

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Measurement of the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2
Sign or acronym NICORISCOVID
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation APHP200663
General Aspects
Medical area Infectious diseases
Study in connection with Covid-19 Yes
Health determinants Lifestyle and behavior
Keywords tobacco nicotine Covid
Scientific investigator(s) (Contact)
Name of the director KARMOCHKINE
Surname Marina
Address Service ImmunoInfectieux<br>Hôtel Dieu<br>Place du Parvis Notre Dame<br>75004 Paris
Phone 142348469
Email marina.karmochkine@aphp.fr
Unit no
Organization AP-HP
Collaborations
Participation in projects, networks and consortia No
Funding
Details no funding
Governance of the database
Sponsor(s) or organisation(s) responsible AP-HP
Organisation status Public
Presence of scientific or steering committees Yes
Labelling and database evaluation Paris Descartes CRU/CIC
Additional contact
Email yannick.vacher@aphp.fr
Main features
Type of database
Type of database Study databases
Study databases (details) Case control study
Database recruitment is carried out by an intermediary A population file
Database recruitment is is made on the basis of: Another treatment or procedure
Database recruitment is carried out as part of an interventional study Yes
Details Performed at individual level
Additional information regarding sample selection. Healthcare professionals having attended the Hôtel Dieu Covid screening centre in March-April 2020, tested by nasal SARS CoV2 PCR
CASES: PCR+
CONTROLS: PCR-
Database objective
Main objective Measure the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2
Inclusion criteria Care personnel having attended the Hôtel-Dieu Hospital Covid screening centre for symptoms compatible with SARS-CoV2 infection,
-Aged over 18 years,
With an email address,
-Able to express non-objection (=questionnaire feedback
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Population covered General population
Pathology
Gender Male
Woman
Geography area Regional
French regions covered by the database Île-de-France
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2020
Date of last collection (YYYY or MM/YYYY) 2020
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 1000
Data
Database activity Current data collection
Type of data collected Declarative data
Declarative data (detail) Internet self-questionnaire
Details of collected declarative data questionnaire consommation tabac et substituts nicotiniques au moment de la réalisation de la PCR SARS-Cov2
Presence of a biobank No
Health parameters studied Others
Other (detail) tobacco use and nicotine replacements
Procedures
Data collection method Lime Survey anonymous questionnaire
Participant monitoring No
Followed pathology
Links to administrative sources No
Promotion and access
Promotion
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here